Back to Search
JOHN STOCK, MD
MD
Pediatric Cardiology Physician
NPI: 1366467094Individual
Specialties, Licenses & Credentials
Pediatric Cardiology PhysicianPrimary
Pediatrics — Pediatric Cardiology
Code: 2080P0202X
25426(AZ)
Research & Publications (20)
Body size estimation of small-bodied humans: Applicability of current methods.
PMID 19591210·Am J Phys Anthropol·2010
8-other
Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus.
PMID 19636380·PLoS One·2009
8-other
Outcomes of genetics services: creating an inclusive definition and outcomes menu for public health and clinical genetics services.
PMID 19621453·Am J Med Genet C Semin Med Genet·2009
8-other
Re: The malone antegrade continence enema: single institutional review A. H. Bani-Hani, M. P. Cain, M. Kaefer, K. K. Meldrum, S. King, C. S. Johnson and R. C. Rink J Urol 2008; 180: 1106-1110.
PMID 19303085·J Urol·2009
8-other
Intensity, repetitiveness, and directionality of habitual adolescent mobility patterns influence the tibial diaphysis morphology of athletes.
PMID 19358289·Am J Phys Anthropol·2009
8-other
(S)-N-(5-Chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol a Notch-1-sparing gamma-secretase inhibitor.
PMID 19097890·Bioorg Med Chem Lett·2009
7-preclinical
Habitual throwing and swimming correspond with upper limb diaphyseal strength and shape in modern human athletes.
PMID 19358297·Am J Phys Anthropol·2009
8-other
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
PMID 19068318·Am J Cardiol·2008
6-review
The Self-Management of OsteoArthritis in Veterans (SeMOA) Study: design and methodology.
PMID 18206425·Contemp Clin Trials·2008
2-rct
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.
PMID 18958843·Diab Vasc Dis Res·2008
6-review
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocket.
PMID 18068983·Bioorg Med Chem Lett·2008
7-preclinical
Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitors.
PMID 18783200·J Med Chem·2008
7-preclinical
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets.
PMID 18162398·Bioorg Med Chem Lett·2008
8-other
Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
PMID 19012391·J Med Chem·2008
7-preclinical
Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.
PMID 18556202·Bioorg Med Chem Lett·2008
8-other
Utility of a novel Oatp1b2 knockout mouse model for evaluating the role of Oatp1b2 in the hepatic uptake of model compounds.
PMID 18556442·Drug Metab Dispos·2008
7-preclinical
Structural mechanism of demethylation and inactivation of protein phosphatase 2A.
PMID 18394995·Cell·2008
7-preclinical
Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial.
PMID 17892376·J Bone Miner Res·2008
4-observational
Endothelial NO-synthase intron 4 polymorphism is associated with disturbed in vivo nitric oxide production in individuals prone to type 2 diabetes.
PMID 18095216·Horm Metab Res·2008
8-other
Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin.
PMID 18413659·Mol Pharmacol·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7505 S MCCLINTOCK DR, STE 103
TEMPE, AZ 85283 - Phone
- (480) 755-1000
Quick Facts
- NPI
- 1366467094
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile